SCHEMBL27865701

SCHEMBL27865701

COc1cccc(F)c1-c1ccc2ncc(N3CCCCC3)nc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 10/20 0.52
▸ PIK3CA P42336 1/20 0.45
▸ MAPT P10636 3/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ HCRTR1 O43613 2/20 0.44
▸ HCRTR2 O43614 2/20 0.44
▸ PIM1 P11309 1/20 0.43
▸ PIM3 Q86V86 1/20 0.43
▸ PIM2 Q9P1W9 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ NFKB2 Q00653 1/20 0.43
▸ RELA Q04206 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ MAPK3 P27361 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ PTPN11 Q06124 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27882090 0.90 MAP4K1 (0.54) MAP4K1PIK3CAMAPTNPC1RAB9A
SCHEMBL12812402 0.89 PIM1 (0.52) MAP4K1PIK3CAMAPTNPC1RAB9A
SCHEMBL12812447 0.85 PTPN11 (0.46) MAP4K1PIK3CAMAPTNPC1RAB9A
SCHEMBL1442090 0.84 PDGFRB (0.51) PIK3CAMAPTNPC1RAB9AALDH1A1
SCHEMBL27865822 0.84 PIK3CA (0.48) MAP4K1PIK3CAMAPTNPC1RAB9A
SCHEMBL27865655 0.83 MAPT (0.44) MAP4K1PIK3CAMAPTNPC1RAB9A
SCHEMBL27882148 0.83 PIK3CA (0.51) PIK3CAMAPTNPC1RAB9AALDH1A1
SCHEMBL1442139 0.82 ALDH1A1 (0.47) PIK3CAMAPTNPC1RAB9AALDH1A1
SCHEMBL1442175 0.82 PIK3CA (0.50) PIK3CAMAPTNPC1RAB9AALDH1A1
SCHEMBL1442693 0.82 HCRTR2 (0.45) PIK3CAMAPTNPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102596932-A Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors BAYER SCHERING PHARMA AG 2012-07-18 — — CN claimed
Send feedback